Human leukocyte interferon in the treatment and prophylaxis of acute hemorrhagic conjunctivitis.

We thank Drs. Ellen Koenig and Ivan L'Official for assistance; the family of Dr. Espaillat Cabral of the Ministry of Health of Santo Domingo, the American Embassy in Santo Domingo, and Dr. Miles Galin for their interest in and logistical support of this investigation; and the Revlon Health Care Group for providing interferon and partial funding for this study. Informed consent was obtained from all participants or from their parents or guardians. Clinical research was conducted in accordance with guidelines for human experimentation of Louisiana State University and the U.S. Department of Health and Human Services. Please address requests for reprints to Dr. S. K. Stansfield at her present address: Medical Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21701.